The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Oncolytics Biotech Inc unchanged

Oncolytics Biotech Inc is unchanged today sitting at $0.36. Shares have lost 10.00% over the last five days, but have gained 35.85% over the last year to date. This security has underperformed the S&P TSX by 22.91% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.11
Updated March 1 1:32 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense3344
Selling / general / administrative0000
Research & development2232
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total1111
Operating income-3-3-4-4
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax-3-3-4-3
Income after tax-3-3-4-3
Income tax, total0000
Net income-3-3-4-3
Total adjustments to net income--------
Net income before extra. items-3-3-4-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-3-3-4-3
Inc. avail. to common incl. extra. items-3-3-4-3
Diluted net income-3-3-4-3
Dilution adjustment0000
Diluted weighted average shares121120118118
Diluted EPS excluding extraordinary itemsvalue per share-0.03-0.02-0.03-0.03
Dividends per sharevalue per share0.
Diluted normalized EPSvalue per share-0.03-0.02-0.03-0.03